Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPY19L4 encodes a probable C-mannosyltransferase, an enzyme believed to catalyze the C-mannosylation of tryptophan residues on target proteins, a specific type of glycosylation involved in modulating protein structure and function[1][3][5][7]. The protein is predicted to be a multi-transmembrane protein localized to the endoplasmic reticulum membrane and is part of the evolutionarily conserved DPY19L family[2][7]. While no detailed characterization of DPY19L4 itself currently exists, studies of other DPY19L family members suggest likely involvement in protein glycosylation, cell adhesion, and possibly neuronal development[2]. DPY19L4 is classified as a protein coding gene; mutations in related family members are implicated in human diseases such as male infertility due to globozoospermia, but there is currently limited direct disease or drug-target evidence specific to DPY19L4[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable C-mannosyltransferase DPY19L4 (DPY19L4).